当前位置： SCI文献检索 > OPHTHALMIC RESEARCH期刊下所有文献 > Effects of multiple doses of voriconazole on the vision of healthy volunteers: a double-blind, placebo-controlled study.

Effects of multiple doses of voriconazole on the vision of healthy volunteers: a double-blind, placebo-controlled study.

Abstract：

PURPOSE:To investigate the effects, and their reversibility, of multiple oral voriconazole doses on a variety of visual tests in healthy male volunteers. METHODS:Single-center, double-blind, randomized, placebo-controlled, parallel-group study in 36 volunteers who received voriconazole (n=18, 400 mg every 12 h on day 1, then 300 mg every 12 h for 27.5 days) or matched placebo (n=18). Electroretinograms (ERGs) and ophthalmological examinations were performed at screening, throughout the study and at follow-up. RESULTS:Fifteen (83.3%) volunteers treated with voriconazole experienced ≥1 treatment-related visual adverse events (AEs); these included enhanced visual perceptions, blurred vision, color vision changes and photophobia. No serious AEs were reported. Voriconazole reduced from baseline scotopic maximal a- and b-wave amplitude, shortened implicit time and decreased oscillatory potential amplitude compared with placebo. Under photopic conditions, the 30-Hz flicker response amplitude was significantly reduced and was accompanied by a slight but nonsignificant prolongation of peak time. These effects did not progress in degree over the treatment period, and mean changes from baseline in ERG parameters were similar to placebo by day 43 (14 days after end of treatment). In the first week, color vision discrimination was impaired in the tritan axis, although this resolved by end of treatment and was similar to placebo by day 43. Mean deviation in the static visual field indicated increased sensitivity following voriconazole treatment, correlating with decreased amplitude in conjunction with shortened implicit time. CONCLUSIONS:Effects of voriconazole on altered visual perception, ERG, color vision and static visual field thresholds are nonprogressive over a treatment period and reversible. It is hypothesized that voriconazole has a pharmacological effect on rod and cone pathways including a possible mechanism of disinhibition that reversibly puts the retina in a more light-adapted state and leads to increased relative contrast sensitivity.

journal_name

Ophthalmic Res

journal_title

Ophthalmic research

authors

Zrenner E,Tomaszewski K,Hamlin J,Layton G,Wood N

doi

10.1159/000359952

subject

Has Abstract

pub_date

2014-01-01 00:00:00

pages

43-52

issue

eissn

0030-3747

issn

1423-0259

pii

000359952

journal_volume

pub_type

杂志文章,随机对照试验

在线工具

Effects of multiple doses of voriconazole on the vision of healthy volunteers: a double-blind, placebo-controlled study.